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In the title compound, C 23 H 22 BrNO, the cycloheptane ring adopts a chair conformation. The pyridine ring makes dihedral angles of 58.63 (15) and 8.27 (16) with the benzene rings. The dihedral angle between the benzene rings is 56.68 (17) . The crystal packing features C-BrÁ Á Á interactions [BrÁ Á Ácentroid distances= 3.813 (2) and 3.839 (2) Å ; C-BrÁ Á Ácentroid = 126.25 (10) and 138.31 (10) , respectively, forming a three dimensional supramolecular architecture.
Related literature
For the biological and pharmacological properties of pyridinebased heterocycles, see: Aida et al. (2009) ; Ceylan & Gezegen (2008) ; Cundy et al. (1997) ; El-borai et al. (2012) ; Gezegen et al. (2010) ; Girgis et al. (2007) ; Hatanaka et al. (2005) ; Khidre et al. (2011) ; Laine-Cessac et al. (1997) ; Menegatti et al. (2006) ; Musiol et al. (2007) ; Rajanarendar et al. (2012) . For ring conformation analysis, see: Cremer & Pople (1975 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) ; software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009 ). supplementary materials Acta Cryst. (2013) . E69, o956 [doi:10.1107/S1600536813013913] 2-(4-Bromophenyl)-4-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclo-
hepta[b]pyridine
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Pyridine based heterocycles are found in structure of many natural and biologically important compounds (Aida et al., 2009; Laine-Cessac et al., 1997; Musiol et al., 2007) . Also they are known to exhibit numerous biological and pharmacological properties such as antimicrobial (El-borai et al., 2012) , antifungal (Khidre et al., 2011) , antiviral (Cundy et al., 1997) , anticancer (Rajanarendar et al., 2012) , antioxidant (Hatanaka et al., 2005) , anti-inflammatory (Girgis et al., 2007) and analgesic (Menegatti et al., 2006) activities. In this paper we report synthesis of 2-(4-bromophenyl)-4-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine with high yield and its crystal structure.
The molecular structure of the title compound (I) is shown in Fig. 1 . The cycloheptane ring (C4-C10) of (I) adopts a chair conformation [the puckering parameters (Cremer & Pople, 1975) Experimental 2-(4-Bromophenyl)-4-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine was synthesized from the 1,5diketone derivative (Ceylan & Gezegen, 2008) according to the literature method (Gezegen et al., 2010) . To a solution of 2-[3-(4-bromophenyl)-1-(4-methoxyphenyl)-3-oxopropyl]cycloheptanone (1 mmol) in EtOH-AcOH (20 ml 1:1 v/v) was added NH 4 Ac (4 mmol) and the mixture refluxed for 6 h. After completion of the reaction, the solvent was removed under vacuum and the residue was extracted with CH 2 Cl 2 (2 × 25 ml). The organic layer was dried over Na 2 SO 4 and evaporated. The crude product was purified by column chromatography (on a silica gel) eluting with hexane/CHCl 3 (3:1 v/v). The obtained brown product was crystallized from EtOH to give pure 2-(4-bromophenyl)-4-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine in 95% yield; m. p. = 396-398 K.
Refinement
H-atoms were positioned geometrically and refined using a riding model with C-H = 0.93-0.97 Å, and with U iso (H) = 1.2 or 1.5U eq (C). Crystals of the title compound were of limited quality. Even though it was possible to select a specimen suitable for X-ray diffraction experiment, the data obtained were rather poor and the value of R int remained high (17.8%). 
Computing details
Data collection: X-AREA (Stoe & Cie, 2002) ; cell refinement: X-AREA (Stoe & Cie, 2002) ; data reduction: X-RED32 (Stoe & Cie, 2002) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure:
SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) ; software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009 ).
Figure 1
The molecular structure of the title compound with displacement ellipsoids drawn at the 30% probability level. Special details Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles Refinement. Refinement on F 2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The observed criterion of F 2 > σ(F 2 ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq Br1 0.22100 (4) 0.14765 (5) (6) C20-H20 0.9300 C18-C19 1.379 (5) C22-H22 0.9300 C18-C23 1.390 (4) C23-H23 0.9300 C19-C20 1.381 (5) 
